Bank of America's (NYSE: BAC ) stock is taking a beating this morning, in a startling turnaround from last week's rally that buoyed the share price above $13, where it hovered all weekend. Unfortunately, it looks as if the great news of the bank's settlement with monoline insurer MBIA (NYSE: MBI ) , which brought an unpleasant legal skirmish to an end, has worn off with the advent of Monday morning.
Bank of America's peers aren't looking too perky, either. Both Wells Fargo (NYSE: WFC ) and JPMorgan Chase (NYSE: JPM ) are down so far, as is Citigroup (NYSE: C ) . Of course, JPMorgan has a right to be depressed, as the legal and political problems mount, both for the bank and for CEO Jamie Dimon himself. The others have legal problems bubbling up, too: Wells, along with B of A, is being sued by New York's Attorney General for mortgage settlement abuses, and Citi faces an action��over a secretary it provided to William Salomon, of the late-but-not-so-great Salomon Brothers investment firm.
Top 10 Diversified Bank Stocks To Buy For 2014: Tintina Mines Ltd (TTS.V)
Tintina Mines Limited, a development stage company, engages in the evaluation, acquisition, and exploration of gold and base mineral properties in Canada. Its principal asset includes the Red Mountain molybdenum deposit located in the Whitehorse Mining district in Yukon, Canada. The company was incorporated in 1961 and is based in Toronto, Canada.
Top 10 Diversified Bank Stocks To Buy For 2014: Books-A-Million Inc.(BAMM)
Books-A-Million, Inc. operates as a book retailer in the southeastern United States. The company operates superstores and traditional bookstores that offer a selection of hardcover and paperback books, magazines, and newspapers. It also offers other merchandise, including gifts, cards, collectibles, magazines, music, DVDs, and electronic accessories, as well as coffee, tea, and other edible products. The company markets its products under the trademarks of Books-A-Million, BAM! Books-A-Million, Bookland, Books & Co., Millionaire?s Club, Sweet Water Press, Thanks-A-Million, Big Fat Coloring Book, Up All Night Reader, Read & Save Rebate, Readables Accessories for Readers, Kids-A-Million, Teachers First, The Write-Price, Bambeanos, Hold That Thought, Book$mart, BAMM, BAMM.com, BOOKSAMILLION.com, Chillatte, Joe Muggs Newsstand, Page Pets, JOEMUGGS.com, FAITHPOINT.com, Faithmark, Joe Muggs, Anderson?s Bookland, Snow Joe, Summer Says, On the John University, OTJU, American Whole sale Book Company, AWBC, and NetCentral. It also offers its products over the Internet at Booksamillion.com. As of August 11, 2011, the company operated 231 stores in 23 states and the District of Columbia. Books-A-Million, Inc. was founded in 1917 and is based in Birmingham, Alabama.
Advisors' Opinion:- [By John Udovich]
Vitamin Shoppe Inc (NYSE: VSI), Books-A-Million, Inc (NASDAQ: BAMM) and Perfumania Holdings, Inc (NASDAQ: PERF) have the dubious distinction of being�the worst performing small cap�specialty retail stocks for this year (according to Finviz.com) with losses of 4.85% and�3% and a gain of 0.61%, respectively, since the start of the year (See my previous article: This Year�� Best Performing Small Cap Specialty Retail Stocks? UNTD, TA & HZO). I should mention that the definition of specialty retail stocks might vary from one stock screener to another, but what�� clear is that these three small cap retail stocks have been heading in the wrong direction for investors for much of this year. �With that in mind, what sort of performance should investors expect from these small cap specialty retail stocks on Black Friday and for the all important holiday season? Here is what you need to be aware of:
Top Communications Equipment Stocks To Buy Right Now: Sutron Corporation(STRN)
Sutron Corporation designs, manufactures, and markets products and solutions for the collection and monitoring of hydrological, meteorological, and oceanic data for the management of critical water resources and optimization of hydropower plants, as well as for warning of disastrous floods, storms, or tsunamis. The company?s Hydromet Products division manufactures real-time data collection and control products consisting of dataloggers, satellite transmitters/loggers, water level and meteorological sensors, and tides monitoring systems. Its Integrated Systems division provides system integration services consisting of the design, integration, installation, and commissioning of customer-specific hydrological and meteorological monitoring and control systems. These systems also include software applications based on it XConnect database software and Ilex Tempest database software. This division also integrates and installs airport weather systems. The company?s Hydrological Services division provides hydrologic services, including data interpretation and analysis, flow modeling, field studies, hydrologic studies, environmental permitting, legal or expert witness and equipment integration, installation, commissioning, and maintenance services. Its Ilex division offers Tempest database software, DOMSAT systems, custom software, and engineering services. The company primarily serves federal, state, local, and foreign governments; engineering companies; universities; and hydropower companies. Sutron Corporation markets its products through direct sales force in the United States, as well as through resellers and agents in Canada, Latin and South America, Europe, Africa, Asia, and Australia. The company was founded in 1975 and is headquartered in Sterling, Virginia.
Top 10 Diversified Bank Stocks To Buy For 2014: Solazyme Inc (SZYM.O)
Solazyme, Inc. (Solazyme), incorporated on March 31, 2003, makes oil. The Company�� technology transforms a range of plant-based sugars into oils. Its renewable products can replace or enhance oils derived from the world�� three existing sources-petroleum, plants and animal fats. The Company is focused on commercializing its products into three target markets: fuels and chemicals, nutrition, and skin and personal care. In 2010, the Company launched its products, the Golden Chlorella line of dietary supplements. In March 2011, the Company launched its Algenist brand for the luxury skin care market through marketing and distribution arrangements with Sephora S.A. (Sephora International), Sephora USA, Inc. (Sephora USA), and QVC, Inc. (QVC).
The Company is engaged in development activities with multiple partners, including Chevron U.S.A. Inc., through its division Chevron Technology Ventures (Chevron), The Dow Chemical Company (Dow), Ecopetrol S.A. (Ecope trol), Qantas Airways Limited (Qantas) and Conopoco, Inc., doing business as Unilever (Unilever).
In 2010, the Company entered into a 50/50 joint venture with Roquette Freres, S.A. (Roquette). In November 2010, the Company entered into a joint venture and operating agreement for Solazyme Roquette Nutritionals with Roquette. In December 2010, the Company entered into an exclusive distribution relationship with Sephora International, and in January 2011, the Company entered into a distribution relationship with Sephora USA. Under the arrangements, each of Sephora International and Sephora USA will distribute the Algenist product line in their respective territories.
In Fuels and Chemicals market its renewable oils can be refined and sold as drop-in replacements for marine, motor vehicle and jet fuels, as well as replacements for chemicals that are traditionally derived from petroleum or other conventional oils. The Company work with its refining par tner Honeywell UOP to produce Soladiesel (renewable diesel! ),! Soladiesel renewable diesel for United States Naval vessels, and Solajet renewable jet fuel for both military and commercial application testing. In nutrition market the Company has developed microalgae-based food ingredients, including oils and powders that enhance the nutritional profile and functionality of food products while reducing costs for consumer packaged goods (CPG) companies. In Skin and Personal Care market the Company hs developed a portfolio of branded microalgae-based products. Its ingredient is Alguronic Acid, which the Company has formulated into a range of skin care products with anti-aging benefits. The Company is also developing algal oils as replacements for the oils used in skin and personal care products.
The Company competes with BP p.l.c., Royal Dutch Shell plc, and Exxon Mobil Corporation, jatropha, camelina, SALOV North America Corporation, Archer Daniels Midland Company, Cargill, Incorporated, DSM Food Specialties and Danisco A/S< /p>
Top 10 Diversified Bank Stocks To Buy For 2014: United Therapeutics Corporation(UTHR)
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and internationally. It offers Remodulin, Tyvaso, and Adcirca for the treatment of pulmonary arterial hypertension (PAH). The company also develops Oral Treprostinil (UT-15C), a new drug application filed with the United States Food and Drug Administration for the treatment of PAH. Its development products under Phase III clinical trials include Oral Treprostinil (UT-15C) Combination Therapy for PAH; Ch14.18 monoclonal antibody (MAb) targeting Neuroblastoma; and Remodulin for the treatment of PAH in the United States, the United Kingdom, France, Germany, Italy, and Japan. The company?s development products under Phase I clinical trials comprise Beraprost-MR for PAH in North America, Europe, Mexico, South America, Egypt, India, South Africa, and Australia; 8H9 MAb targ eting Metastatic brain cancer; and IW001 for the treatment of Idiopathic pulmonary fibrosis and primary graft dysfunction. Its pre-clinical stage products consist of Glycobiology Antiviral Agents for viral infectious diseases; PLacental eXpanded cells targeting PAH; and pulmonary tissue replacement and remodeling products for the treatment of end-stage lung disease. The company serves pharmaceutical wholesalers through specialty pharmaceutical distributors and other distributors. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland.
Advisors' Opinion:- [By John Udovich]
Yesterday, mid cap biotech stock�United Therapeutics Corporation (NASDAQ: UTHR) soared�30.36% after announced FDA approval of Orenitram as�an oral treatment for pulmonary arterial hypertension (PAH), meaning investors should take a closer look at the stock along with the performance of peers like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and the�SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By Monica Gerson]
United Therapeutics (NASDAQ: UTHR) shares reached a new 52-week high of $91.13. United Therapeutics' PEG ratio is 1.64.
DENTSPLY International (NASDAQ: XRAY) shares touched a new 52-week high of $47.65. DENTSPLY's trailing-twelve-month ROE is 15.95%.
- [By Ben Levisohn]
Look up in the sky! It’s a bird! It’s a plane! It’s Santa Claus! No. It’s United Therapeutics (UTHR).
ReutersShares of the United Therapeutics have surged 23% to $107.65, on what’s looking to be a pretty decent day for biotech stocks. The iShares Nasdaq Biotechnology Index ETF (IBB) has gained 0.9% to $225.75, as Gilead Sciences (GILD) has risen 0.7% to $75.16 and Celgene (CELG) has ticked up 0.4% to $168.09.
Top 10 Diversified Bank Stocks To Buy For 2014: Celeste Mining Corp.(C.V)
Celeste Mining Corp., a junior natural resource company, engages in the acquisition, exploration, and development of mineral properties in Chile. It primarily explores for tin, copper, gold, and silver ores. The company holds an option agreement to acquire a 100% interest in seven exploration concessions, Celeste IV�X, covering approximately 2,765 hectares located in the Cabeza de Vaca mineral district, Chile. It also holds three exploration concessions in the Manto Medio district of Chile. The company was formerly known as Celeste Copper Corporation and changed its name to Celeste Mining Corp. in November 2012. Celeste Mining Corp. was incorporated in 2007 and is based in Calgary, Canada.
Top 10 Diversified Bank Stocks To Buy For 2014: Express Scripts Holding Co (ESRX)
Express Scripts Holding Company, incorporated in 2011, provides healthcare management and administration services on behalf of its clients, which include health maintenance organizations (HMOs), health insurers, third-party administrators, employers, union-sponsored benefit plans, workers compensation plans, and government health programs. The Company operates in two segments: Pharmacy Benefit Management (PBM) and Emerging Markets (EM). PBM services include network claims processing, home delivery services, patient care and direct specialty and fertility home delivery to patients, benefit plan design consultation, drug utilization review, formulary management, drug data analysis services, distribution of injectable drugs to patients homes and physicians offices, bio-pharma services, and fulfillment of prescriptions to low-income patients through manufacturer-sponsored patient assistance programs. EM segment provides distribution of pharmaceuticals and medical supplies to providers and clinics, healthcare account administration and implementation of consumer-directed healthcare solutions. In September 2013, it announced the acquisition of the SmartD Medicare Prescription Drug Plan (PDP).
On July 20, 2011, Express Scripts, Inc. (ESI) entered into a merger agreement (the Merger Agreement) with Medco Health Solutions, Inc. (Medco). During the year ended December 31, 2011, it reorganized its FreedomFP line of business from its EM segment into its PBM segment. On April 2, 2012, the Company completed the Merger Agreement, and after which ESI and Medco became the wholly owned subsidiaries of the Company. The Company�� customers include HMOs, health insurers, third-party administrators, employers, union-sponsored benefit plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists and others.
Advisors' Opinion:- [By Sean Williams]
Another challenge for Walgreen is its still impaired relationship with pharmacy-benefits management company Express Scripts (NASDAQ: ESRX ) and its members. Although Walgreen and Express Scripts came to a multi-year agreement that allowed Express Scripts members to again fill their prescriptions at Walgreen as of September, close to eight months went by last year where the two weren't partners, allowing its competitors to gobble up pharmacy prescriptions for Express Scripts members. Express Scripts may have forgiven and forgotten, but consumers may not be so easy to win over.�
- [By Adam Levine-Weinberg]
Strong results, modest outlook
Rite Aid's profit was driven by three major one-time or short-term impacts. First, the company gained a number of new customers from Walgreen's dispute with pharmacy benefits manager Express Scripts (NASDAQ: ESRX ) . Walgreen's stores rejoined the Express Scripts network as of Sept. 15, and customers are beginning to trickle back, but Rite Aid still saw a significant benefit from the dispute in fiscal year 2013. On Rite Aid's Thursday morning conference call, executives estimated the full-year benefit at $70 million�-- more than half of the company's fiscal year 2013 profit. - [By Holly LaFon] ss Scripts is a pharmacy benefit manager that generates revenue through delivering prescription drugs through its network of contracted retail pharmacies, specialty pharmacy services, home delivery and EM services.
Express Scripts��stock tumbled to a 52-week low of $34.37 at the end of the third quarter, from a high of $60.89. Cooperman bought 719,000 shares of the company at an average of $43 per share. He previously owned shares of Express Scripts in 2007 when the price was about $23 per share, and sold over the next several quarters as the stock climbed to $34 in the second quarter of 2008, when he closed his position.
Express Scripts Inc. has a market cap of $24.76 billion; its shares were traded at around $50.17 with a P/E ratio of 17.8 and P/S ratio of 0.5. Express Scripts Inc. had an annual average earnings growth of 28.6% over the past 10 years. GuruFocus rated Express Scripts Inc. the business predictability rank of 5-star.
Over the past decade, Express Scripts has generated strong and growing free cash flow, which grew from $1.6 billion in 2009 to a record of almost $2 billion in 2010.
In October, the company had to lower its earnings per share guidance from the previously expected $3.15 to $3.25, to a range of $2.95 to $3.05. The decrease was due to multiple factors: a greater shortfall in claims versus expectations, a stagnant economy impacting claims volumes, additional expenses, including accelerating spending on projects in preparation for the integration of Medco Health Solutions Inc., expenses to support clients and members as they transfer from Walgreen�� pharmacies and to comply with new regulations. The company is also facing heightened competition.
Later, on October 25, the company announced that it expects 95% of its clients��prescription volume to continue after it loses Walgreens as a network supplier in 2012. It also expects that the merger with Medco, another PBM, will be slightly accretive to EPS in
- [By Keith Speights]
The aftermath of the dispute with Express Scripts (NASDAQ: ESRX ) also continues to play a factor for Walgreen. After the two sides couldn't come to an agreement, Walgreen allowed its contract with Express Scripts to expire at the end of 2011.
Top 10 Diversified Bank Stocks To Buy For 2014: Merit Medical Systems Inc.(MMSI)
Merit Medical Systems, Inc. designs, develops, manufactures, and markets medical devices for use in interventional and diagnostic procedures worldwide. It offers cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease, and other non-vascular diseases. The company?s cardiology and radiology devices include inflation devices; hemostasis valves; vascular retrieval devices; vascular access products; diagnostic catheters; guide wires and torque devices; and angiography and angioplasty accessories. Its cardiology and radiology devices also comprise safety and waste management systems; radial artery compression devices; drainage catheters and accessories; paracentesis, thoracentesis, and pericardiocentesis catheters; therapeutic infusion catheters; embolic microspheres; multipurpose microcatheters; and dialysis and interventional nephrology products. The company also provides gastroenterology and pulmonolog y devices that assist in the palliative treatment of expanding esophageal, tracheobronchial, and biliary strictures caused by malignant tumors. Its gastroenterology and pulmonology devices consist of airway, esophageal, and biliary stents; stent sizing devices; guide wires for non-vascular procedures; bipolar coagulation probes; inflation devices; and cholangiography rapid refill continuous injection kits, as well as specialty devices and accessories, such as discography products and pressure sensors. The company sells its products through direct sales force, distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. Its customers include hospitals and clinic-based cardiologists, radiologists, anesthesiologists, physiatrists, neurologists, nephrologists, vascular surgeons, interventional gastroenterologists and pulmonologists, thoracic surgeons, technicians, and nurses. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Top 10 Diversified Bank Stocks To Buy For 2014: Glen Eagle Res Inc(GER.V)
Glen Eagle Resources Inc. engages in the acquisition, exploration, production, development, and operation of mining properties. The company explores primarily for lithium and gold ores. Its principal property includes the Authier lithium project, which is located in Lamothe, Quebec. The company was formerly known as Temoris Resources Inc. and changed its name to Glen Eagle Resources Inc. in August 2008. Glen Eagle Resources Inc. is headquartered in Montreal, Canada.
Top 10 Diversified Bank Stocks To Buy For 2014: Electrovaya Inc Com Npv (EFL.TO)
Electrovaya Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of batteries, battery systems, and battery-related products for the electric transportation, utility scale energy storage and smart grid power, consumer, and healthcare markets in Canada. It develops portable power technology products using its Lithium Ion SuperPolymer technology. The company offers battery systems for plug in hybrid electric vehicles, electric vehicles, and two-wheel vehicles, as well as for commercial truck and offroad applications; and PowerPad series of batteries for notebook computers and other mobile applications, as well as Scribble Tablet PC products for the health care industry. It also provides cells and battery modules; and intelligent battery management systems for automotive, utility-scale, and other integrated systems. The company was formerly known as Electrofuel Inc. and changed its name to Electrovaya Inc. in March 2002. Electro vaya Inc. was founded in 1996 and is headquartered in Mississauga, Canada.
Top 10 Diversified Bank Stocks To Buy For 2014: Indico Resources Ltd. (IDI.V)
Indico Resources Ltd., an exploration stage company, engages in the exploration for and development of natural resources in South America. It holds an option to acquire a 100% indirect interest in the Ocana copper gold porphyry project consisting of 22 concessions in south-central Peru. The company was founded in 1996 and is based in Vancouver, Canada.
No comments:
Post a Comment